Industry | Medical Technology |
---|---|
Founded | 1995 |
Headquarters | Caesarea |
Key people | Giora Yaron, Gilad Glick (President) |
Revenue | 33.2M |
Number of employees | 184 (2019) |
Parent | ZOLL Medical Corporation |
Website | www |
Itamar Medical is a multinational company focused on the development, manufacturing and sales of medical devices related to respiratory sleep disorders. The company is headquartered in Caesarea, Israel [1] and is owned by ZOLL Medical Corporation. The company is a medical device company [2] [3] providing continuum of care in the area of sleep disorder [4] based on its WatchPAT diagnostic devices and early diagnosis of Atherosclerosis. [5] [6] [7]
Itamar Medical was founded in 1995 as a developer of devices for assessing vascular defects. Its early products included technology for early detection of heart disease (EndoPAT) and detection of sleep disorders [8] (WatchPAT). [9] [10] [11] The company is named after Itamar Yaron (one of the founders' brothers), who was killed in the Yom Kippur War when trying to rescue an injured soldier and was lawarded with a Medal of Courage. [12] Itamar's headquarters is located in Caesarea, Israel, and the company has offices in the US, Japan, and the Netherlands.
In 2007, the company went public on the Tel Aviv Stock Exchange and on the Nasdaq. In 2011, the company made its first step on the Indian market. [13] In 2012, the company's WatchPAT started being distributed in Russia by Medical Diagnostic Methods. [14]
In 2020, the company raised $40 million on the NASDAQ [15] [16] and won the SleepTech award for 2020. [17]
In 2021, the company was acquired by ZOLL Medical Corporation and its stock delisted. [18]
Sleep apnea, also spelled sleep apnoea, is a sleep disorder in which pauses in breathing or periods of shallow breathing during sleep occur more often than normal. Each pause can last for a few seconds to a few minutes and they happen many times a night. In the most common form, this follows loud snoring. A choking or snorting sound may occur as breathing resumes. Because the disorder disrupts normal sleep, those affected may experience sleepiness or feel tired during the day. In children, it may cause hyperactivity or problems in school.
Respironics is an American medical supply company owned by Philips that specializes in products that improve respiratory functions. It is based in the Pittsburgh suburb of Murrysville in Pennsylvania, United States.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.
ResMed Inc. is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. ResMed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. ResMed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
Postmarketing surveillance (PMS), also known as post market surveillance, is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance. Since drugs and medical devices are approved on the basis of clinical trials, which involve relatively small numbers of people who have been selected for this purpose – meaning that they normally do not have other medical conditions which may exist in the general population – postmarketing surveillance can further refine, or confirm or deny, the safety of a drug or device after it is used in the general population by large numbers of people who have a wide variety of medical conditions.
RespireRx Pharmaceuticals Inc. is a pharmaceutical company based in Glen Rock, New Jersey specializing in positive allosteric modulators of the AMPA receptor known as Ampakines.
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
D. Medical Industries is a publicly traded holding company, headquartered in Israel, that develops and markets insulin pumps and infusion sets through its subsidiary, Spring-Set Health Solutions. Shares of the company are traded on the Tel Aviv Stock Exchange.
Peretz Lavie was the 16th president of the Technion - Israel Institute of Technology, having taken the position on 1 October 2009 through September 2019. Lavie, an expert in the psychophysiology of sleep and sleep disorders, heads the Technion Sleep Laboratory and holds the André Ballard Chair in Biological Psychiatry. Between 1993 and 1999 he served as dean of the Rappaport Faculty of Medicine, and between 2001 and 2008, as the Technion’s vice president for resource development and external relations.
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.
Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996.
Yoram Harth is an Israeli dermatologist and inventor. He co-invented blue light acne vulgaris phototherapy, as well as a radio frequency device for home treatment for wrinkle reduction.
Solriamfetol, sold under the brand name Sunosi, is a wakefulness-promoting medication used in the treatment of excessive sleepiness related to narcolepsy and sleep apnea. It is taken by mouth.
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring. CardiacSense is based in Caesarea, Israel.
Peripheral Arterial Tone (PAT) is a noninvasive measure designed to track pulsatile volume changes in peripheral arterial beds. The collected information gives specialists important insight into the autonomic nervous system and the cardiovascular system. PAT technology is mostly used to detect heart disease, erectile dysfunction and obstructive sleep apnea.
Sofwave Medical is an Israeli aesthetic medicine company based in Israel with headquarters in California, United States. It is publicly traded, listed on the Tel Aviv Stock Exchange. Sofwave develops an ultrasound system for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles and for short term improvement in the appearance of cellulite.